Mintie Pritchard, PA
Medical · Beckley, WVNPI 1396073656
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 420 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,616 and has fallen 61.7% since, to $618 in 2025. Among medical clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 420 payments — averaging $15.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$924
- Lilly USA, LLC$821
- AstraZeneca$383
- Shield Therapeutics Inc$376
- Boehringer Ingelheim$316
- plus $2K from 31 others
What the payments were for
- Food & beverage$6,551100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 115 | $1,439 |
| Novo Nordisk | 56 | $924 |
| Lilly USA, LLC | 53 | $821 |
| AstraZeneca | 22 | $383 |
| Shield Therapeutics Inc | 13 | $376 |
| Boehringer Ingelheim | 20 | $316 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 21 | $314 |
| Abbott | 15 | $267 |
| Esperion Therapeutics, Inc. | 21 | $218 |
| Amgen | 13 | $193 |
| Bayer | 7 | $188 |
| Pfizer | 7 | $139 |
| GSK | 9 | $127 |
| Novartis | 6 | $121 |
| Merck | 4 | $69 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $55 |
| Phathom Pharmaceuticals, Inc. | 3 | $50 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| Amarin Pharma, Inc. | 3 | $41 |
| Astellas Pharma US Inc | 2 | $40 |
| Exact Sciences | 2 | $39 |
| Johnson & Johnson | 2 | $38 |
| Dexcom, Inc. | 2 | $38 |
| E.r. Squibb & Sons, L.L.C. | 2 | $37 |
| Idorsia Pharmaceuticals US Inc | 2 | $37 |
| Sumitomo Pharma America, Inc. | 3 | $33 |
| Almatica Pharma LLC | 2 | $28 |
| Averitas Pharma Inc. | 1 | $26 |
| Corcept Therapeutics | 1 | $23 |
| Organon | 1 | $23 |
| Optinose US, Inc. | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Redhill Biopharma Inc. | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Exeltis, USA Inc. | 1 | $12 |
How this compares
$6,563 in reported general payments places this provider in the 90th percentile of 233 medical providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 94 | $158,778 |
| MounjaroTirzepatide | 111 | $151,084 |
| EliquisApixaban | 147 | $135,841 |
| JardianceEmpagliflozin | 82 | $107,855 |
| Tresiba Flextouch U-200Insulin Degludec | 54 | $37,545 |
| EntrestoSacubitril/Valsartan | 24 | $33,290 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 34 | $28,435 |
| XareltoRivaroxaban | 23 | $25,151 |
| LinzessLinaclotide | 33 | $24,817 |
| FarxigaDapagliflozin Propanediol | 21 | $22,734 |
| JanuviaSitagliptin Phosphate | 15 | $17,842 |
| BrilintaTicagrelor | 20 | $17,533 |
| MyrbetriqMirabegron | 15 | $15,526 |
| JanumetSitagliptin Phos/Metformin Hcl | 16 | $14,383 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 21 | $13,589 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $821 | $164,546123 claims |
| Novo NordiskOzempic | $924 | $158,77894 claims |
| PfizerEliquis | $139 | $135,841147 claims |
| Boehringer IngelheimJardiance | $316 | $107,85582 claims |
| AstraZenecaFarxiga, Brilinta, Breztri Aerosphere, Symbicort | $383 | $57,46876 claims |
| NovartisEntresto | $121 | $33,29024 claims |
| MerckJanuvia, Janumet | $69 | $32,22531 claims |
| AbbVieLinzess, Synthroid | $1,439 | $29,712100 claims |
| GSKTrelegy Ellipta | $127 | $28,43534 claims |
| Johnson & JohnsonXarelto | $38 | $25,15123 claims |
| Astellas Pharma US IncMyrbetriq | $40 | $15,52615 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $33 | $8,13017 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 233 medical providers in West Virginia.
Other medical in Beckley
- Lauren DillonBeckley$18K
- Erik DanielsBeckley$6K
- Ashlee ThomasBeckley$5K
- Katherine BoggsSouth Charleston$46K
- Lowell LarewMorgantown$31K
- Katie CarpenterSouth Charleston$26K
- Angela HagerFarmington$16K
- Brandon CaragCharleston$16K
- Scott EthridgeCharleston$16K
- Kellie HanselSouth Charleston$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.